BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Astellas Appoints Gary Thal, M.D., to VP, Specialty, Medical Affairs, Americas

  Astellas today announced Gary Thal, M.D., has been promoted to VP, Specialty, Medical Affairs, Americas and will assume overall responsibility for the strategic direction of the Specialty product portfolio.

  October 30, 2017

   · 

  2 min read
• FactBio Launches Annotated Metadata Collection

  The Annotated Metadata Collection covers a wide range of areas such as functional genomics, genomic variation and toxicology.

  October 30, 2017

   · 

  2 min read
• BioMidwest

  Northwestern Medicine Surgeon First in Illinois to Implant Newly FDA-Approved Milestone Device for Advanced Heart Failure Patients

  Garcia sought a second opinion and from that, became the first patient in Illinois to receive the HeartMate 3 LVAD, a new option for physicians managing advanced heart failure patients in need of short-term hemodynamic support.

  October 30, 2017

   · 

  3 min read
• Business

  EXACT Sciences’ Cologuard Revenue Increased 158 Percent to $73M During Third Quarter

  EXACT Sciences today announced that the company generated revenue of $72.6M and completed approximately 161,000 Cologuard tests during the quarter ended Sept. 30, 2017.

  October 30, 2017

   · 

  12 min read
• Business

  Pfenex to Report Third Quarter 2017 Results and Provide Business Update on Thursday, November 9, 2017

  Pfenex announced today that its third quarter 2017 financial results will be released on Thursday, November 9, 2017, after the market close.

  October 30, 2017

   · 

  2 min read
• Business

  Luminex Corporation Reports Third Quarter 2017 Financial Results

  Consolidated revenue of $74.1 million, an increase of 4% compared to the third quarter 2016.

  October 30, 2017

   · 

  25 min read
• Business

  PerkinElmer Elects Pascale Witz to Its Board of Directors

  Witz has more than 30 years of global experience, most recently serving as executive vice president, Global Diabetes and Cardiovascular for Sanofi, S.A.

  October 30, 2017

   · 

  2 min read
• Genetown

  Alnylam to Webcast Conference Call Discussing Third Quarter 2017 Financial Results

  Management will provide an update on the Company and discuss third quarter 2017 results as well as expectations for the future via conference call on Tuesday, November 7, 2017 at 4:30 p.m. ET.

  October 30, 2017

   · 

  2 min read
• Lombard Medical Announces Shares to Trade on OTCQX

  Lombard anticipates that its common shares will trade under its existing ticker symbol EVAR on the OTCQX Market effective as of the market open on November 9, 2017.

  October 30, 2017

   · 

  3 min read
• Drug Development

  Enterome’s EB8018, A First-in-Class Drug Candidate Targeting Crohn’s Disease, Successfully Completes Phase I Study in Healthy Volunteers

  EB8018 was found to be well tolerated in healthy volunteers across a wide range of doses tested

  October 30, 2017

   · 

  4 min read